Market Closed -
Singapore S.E.
06:32:19 02/05/2024 am IST
|
5-day change
|
1st Jan Change
|
0.115
SGD
|
0.00%
|
|
0.00%
|
-22.82%
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
55.07
|
37.89
|
70
|
104.7
|
99.66
|
75.13
|
Enterprise Value (EV)
1 |
50.01
|
42.32
|
78.77
|
113.7
|
118
|
83.49
|
P/E ratio
|
18.6
x
|
8.95
x
|
14.1
x
|
10.3
x
|
11.5
x
|
17.9
x
|
Yield
|
6.88%
|
6.67%
|
2.72%
|
2.2%
|
2.31%
|
3.06%
|
Capitalization / Revenue
|
0.77
x
|
0.45
x
|
0.76
x
|
0.88
x
|
0.73
x
|
0.56
x
|
EV / Revenue
|
0.7
x
|
0.51
x
|
0.86
x
|
0.95
x
|
0.86
x
|
0.63
x
|
EV / EBITDA
|
9.54
x
|
5.16
x
|
7.62
x
|
6.92
x
|
7.03
x
|
6.22
x
|
EV / FCF
|
-8.27
x
|
-5.33
x
|
56.2
x
|
-929
x
|
-17.1
x
|
7.19
x
|
FCF Yield
|
-12.1%
|
-18.7%
|
1.78%
|
-0.11%
|
-5.86%
|
13.9%
|
Price to Book
|
0.95
x
|
0.63
x
|
1.13
x
|
1.46
x
|
1.27
x
|
0.96
x
|
Nbr of stocks (in thousands)
|
5,05,217
|
5,05,217
|
5,07,217
|
5,10,627
|
5,11,077
|
5,11,077
|
Reference price
2 |
0.1090
|
0.0750
|
0.1380
|
0.2050
|
0.1950
|
0.1470
|
Announcement Date
|
02/11/18
|
11/11/19
|
03/11/20
|
01/11/21
|
01/11/22
|
06/11/23
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
71.26
|
83.46
|
91.76
|
119.5
|
136.6
|
133.5
|
EBITDA
1 |
5.243
|
8.196
|
10.34
|
16.44
|
16.79
|
13.42
|
EBIT
1 |
1.671
|
4.258
|
5.924
|
11.63
|
11.85
|
8.31
|
Operating Margin
|
2.34%
|
5.1%
|
6.46%
|
9.73%
|
8.68%
|
6.23%
|
Earnings before Tax (EBT)
1 |
1.58
|
3.978
|
7.17
|
12.3
|
11.01
|
5.609
|
Net income
1 |
2.95
|
4.236
|
4.984
|
10.4
|
8.839
|
4.238
|
Net margin
|
4.14%
|
5.08%
|
5.43%
|
8.7%
|
6.47%
|
3.18%
|
EPS
2 |
0.005861
|
0.008384
|
0.009799
|
0.0200
|
0.0170
|
0.008200
|
Free Cash Flow
1 |
-6.048
|
-7.935
|
1.401
|
-0.1224
|
-6.917
|
11.61
|
FCF margin
|
-8.49%
|
-9.51%
|
1.53%
|
-0.1%
|
-5.07%
|
8.7%
|
FCF Conversion (EBITDA)
|
-
|
-
|
13.54%
|
-
|
-
|
86.5%
|
FCF Conversion (Net income)
|
-
|
-
|
28.1%
|
-
|
-
|
273.97%
|
Dividend per Share
2 |
0.007500
|
0.005000
|
0.003750
|
0.004500
|
0.004500
|
0.004500
|
Announcement Date
|
02/11/18
|
11/11/19
|
03/11/20
|
01/11/21
|
01/11/22
|
06/11/23
|
Fiscal Period: July |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
4.43
|
8.77
|
9.01
|
18.4
|
8.37
|
Net Cash position
1 |
5.06
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.5406
x
|
0.8483
x
|
0.5483
x
|
1.093
x
|
0.6233
x
|
Free Cash Flow
1 |
-6.05
|
-7.93
|
1.4
|
-0.12
|
-6.92
|
11.6
|
ROE (net income / shareholders' equity)
|
5.06%
|
7.04%
|
8.01%
|
15.6%
|
11.8%
|
5.4%
|
ROA (Net income/ Total Assets)
|
1.46%
|
3.4%
|
4.27%
|
7.17%
|
6.12%
|
4.17%
|
Assets
1 |
201.9
|
124.4
|
116.8
|
145.1
|
144.4
|
101.7
|
Book Value Per Share
2 |
0.1100
|
0.1200
|
0.1200
|
0.1400
|
0.1500
|
0.1500
|
Cash Flow per Share
2 |
0.0200
|
0.0100
|
0.0100
|
0.0200
|
0.0200
|
0.0200
|
Capex
1 |
6.54
|
8.16
|
6.42
|
5.16
|
12.5
|
5.29
|
Capex / Sales
|
9.17%
|
9.78%
|
6.99%
|
4.32%
|
9.15%
|
3.96%
|
Announcement Date
|
02/11/18
|
11/11/19
|
03/11/20
|
01/11/21
|
01/11/22
|
06/11/23
|
|
1st Jan change
|
Capi.
|
---|
| -22.82% | 43.59M | | +73.37% | 12.39B | | -17.09% | 8.08B | | +16.88% | 7.25B | | +3.57% | 5.86B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4.19B | | -35.26% | 2.44B | | +3.09% | 2.07B |
Medical Equipment
|